The Patent Finder

Terms ending in 2031

Array Biopharma Inc.

Every in-force patent on Array Biopharma Inc.'s record whose computed term ends in 2031, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 8,933,084Macrocyclic Compounds as TRK Kinase Inhibitors
In force
 · High confidence
Array Biopharma, Inc.In forceHigh confidence
US 9,493,476Macrocyclic Compounds as TRK Kinase Inhibitors
In force
 · High confidence
Array Biopharma, Inc.In forceHigh confidence
US 10,647,730Macrocyclic Compounds as TRK Kinase Inhibitors
In force
 · High confidence
Array Biopharma Inc.In forceHigh confidence
US 9,314,464Compounds and Compositions as Protein Kinase Inhibitors
In force
 · High confidence
Array Biopharma, Inc.In forceHigh confidence
US 8,841,455Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide Compounds as CFMS Inhibitors
In force
 · High confidence
Array Biopharma, Inc.In forceHigh confidence
5 of 5 patents shown. Soonest term end first, then patent number.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited